[Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)]
[Senate]
[Pages S1201-S1202]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 498. Ms. KLOBUCHAR submitted an amendment intended to be proposed 
by her to the concurrent resolution S. Con. Res. 7, setting forth the 
congressional budget for the United States Government for fiscal year 
2025 and setting forth the appropriate budgetary levels for fiscal 
years 2026 through 2034; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING 
                   THE COST OF PRESCRIPTION DRUGS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this

[[Page S1202]]

     resolution, and make adjustments to the pay-as-you-go ledger, 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to lowering the cost of prescription drugs, which 
     may include capping the cost of certain generic prescription 
     drugs under the Medicare program, by the amounts provided in 
     such legislation for those purposes, provided that such 
     legislation would not increase the deficit over the period of 
     the total of fiscal years 2025 through 2034.
                                 ______